The Training to Improve Dyspnoea Study- Patient Experiences of Using a High Frequency Airway Oscillating Device
DOI: https://doi.org/10.2147/copd.s443186
2024-06-14
International Journal of COPD
Abstract:Enya Daynes, 1, 2 Linzy Houchen-Wolloff, 1, 2 Amy C Barradell, 1, 2 Neil J Greening, 1, 2 Sally J Singh 1, 2 1 Leicester NIHR Biomedical Research Centre Respiratory, Glenfield Hospital, Leicester, UK; 2 Department of Respiratory Sciences, University of Leicester, Leicester, UK Correspondence: Enya Daynes, NIHR Leicester Biomedical Research Centre- Respiratory, Glenfield Hospital, Groby Road, Leicester, UK, Email Introduction: The High Frequency Airway Oscillating device (HFAO) was developed to help patients with COPD feel less breathless through flow resistive respiratory muscle training and fixed rate oscillations. Previous work has demonstrated that this device can improve inspiratory muscle strength over and above a sham device. Both groups improved their breathlessness and preserved clinical benefits though there were no statistically significant differences seen over and above the sham device. It is important to understand patient perceptions of using a device and how this may influence their treatment and therefore a qualitative analysis was conducted to understand participant experiences of a HFAO device. Methods: This was an exploratory qualitative analysis involving participants recruited to the Training to Improve Dyspnoea (TIDe) study. Participants completed a satisfaction survey and were invited to take part in a focus group. Focus groups were conducted by a researcher independent to the randomised controlled trial. Data was analysed independently by two researchers using inductive thematic analysis, and themes/sub-themes were agreed jointly. Data is presented in themes and sub themes and triangulated with survey response data. Results: Fourteen participants were recruited to two focus groups (71% male, mean [SD] age 64[9] years). The key themes were patient selection, device use, and investment. Patient selection explores the disease characteristics, emotional impact and management of care. Device use explores the device prescription and usage, routine and lifestyle and effectiveness. Investment covers accessibility, understanding, benefits vs participation and overall perceptions of the device. Conclusion: This research demonstrates the complexity of device interventions and that key considerations should be given to patient selection, the device use itself and, the time and cost investment required for participants to successfully implement the device into daily life. Keywords: COPD, breathlessness, qualitative Chronic Obstructive Pulmonary Disease (COPD) is a disease of the small airways that leads to debilitating breathlessness, which can impact on function and quality of life. 1 Other symptoms such as excessive sputum and cough can co-exist in patients with COPD. 2 Breathlessness is a multifactorial symptom with various pathophysiologies such as inspiratory muscle weakness and inefficiency. Changes in breathing mechanics and an increased work of breathing results in an inability to meet the respiratory demands leading to intolerable breathlessness. 3 The inspiratory muscles are often placed on a stretch due to hyperinflation and have a reduced capacity; this can cause or contribute to breathlessness for some patients. Respiratory muscle training has been used to reduce breathlessness in some groups of patients, particularly those that have a baseline maximal inspiratory pressure of ≤60cmH 2 O. 3,4 There are a variety of different inspiratory muscle training devices that have differing benefits and research has not yet identified which patients have the greatest clinical benefit. 4 Expiratory muscle training or combined respiratory muscle training has been shown to improve breathlessness compared to a control group, however, there is less supporting evidence. 5 Devices have also shown promise in managing excessive sputum and cough through oscillatory positive expiratory pressure, demonstrating significant improvements in sputum volume, cough and quality of life. 6,7 The High Frequency Airway Oscillations (HFAO) (Aerosure ©) device utilises for inspiratory and expiratory muscle training to target breathlessness, and airway oscillations that may improve sputum and quality of life. The HFAO device has demonstrated improvements in respiratory muscle strength and breathlessness in healthy volunteers through flow resistance. 8 The use of HFAO in patients with COPD (the TIDe study) did not demonstrate clinical benefits in breathlessness above a sham, however both groups did improve their breathlessness above established Minimal Clinical Important Differences. The HFAO device demonstrated improves inspirato -Abstract Truncated-
respiratory system